// App-Quantinova.ai

1633 : Vasodilator-stimulated phosphoprotein promotes 1-integrin-FAK-YAP1/TAZ signaling axis that is required for liver metastasis of GI cancer

Researchers

Presenter

  • Xiaoyu Xiang

Principal Investigators

  • Jinhua Piao

  • Selvaraj Muthusamy

  • Lei Wang

  • Yibin Deng

  • Shengbing Huang

  • Raul Urrutia

  • Jinping Lai

  • Ningling Kang

Medical Centers

  • The University of Minnesota, Austin, MN

  • St Louis University, St Louis, MO

  • Mayo Clinic, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

  • Pancreatic cancer

  • Secondary liver cancer

  • Gastric Cancer

  • Solid malignancies

  • Pancreatic and cerebellar agenesis

  • Gastric antral vascular ectasia

Biomarkers

  • Phosphorylated focal adhesion kinase

  • Melanoma-inhibitory activity

  • Tafazzin

  • Vasodilator Stimulated Phosphoprotein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved